MDT - Medtronic plc
112.86 +0.20 (0.18%)
After hours: 5:01PM EST
| Previous Close | 117.33 |
| Open | 114.23 |
| Bid | 112.51 x 900 |
| Ask | 112.90 x 1100 |
| Day's Range | 111.95 - 115.00 |
| 52 Week Range | 82.77 - 122.15 |
| Volume | 11,875,011 |
| Avg. Volume | 4,407,070 |
| Market Cap | 151.007B |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 32.00 |
| EPS (TTM) | 3.52 |
| Earnings Date | Feb 17, 2020 |
| Forward Dividend & Yield | 2.16 (1.84%) |
| Ex-Dividend Date | Dec 25, 2019 |
| 1y Target Est | 126.43 |
- Investor's Business Daily
This Medtech Giant Is Grappling To Stay In A Buy Zone On Mixed Earnings
Shares of Medtronic stock grappled to stay in a buy zone Tuesday after the medical technology company issued a "noisy" fiscal third-quarter earnings report, according to one analyst.
- Zacks
Tandem Diabetes Hits New 52-Week High: What's Driving It?
Tandem Diabetes (TNDM) is optimistic about maintaining growth momentum on several recent developments.
- American City Business Journals
The list of insurers covering Senseonics’ diabetes device is growing. The latest? Cigna.
Cigna is one of a handful of private payers now covering the local company's product, which measures glucose levels for diabetes patients.
- Zacks
Medtronic (MDT) Q3 Earnings Top Estimates, Revenues Miss
Medtronic (MDT) demonstrates better-than-expected Q3 performances at CER, backed by growth in all major business segments and geographies.
- American City Business Journals
Medtronic tops profit target but says coronavirus could impact Q4 results
Medtronic on Tuesday warned that the fourth quarter could be hurt by a slowdown caused by the COVID-19 virus that has sickened tens of thousands in China and elsewhere.
- MarketWatch
Medtronic's stock falls after profit beats but sales comes up shy
Shares of Medtronic PLC fell 1.4% in premarket trading Tuesday, after the Dublin-based medical technology company reported a fiscal third-quarter profit that beat expectations but revenue that missed. Net income rose to $1.92 billion, or $1.42 a share, from $1.27 billion, or 94 cents a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share came to $1.44, above the FactSet consensus of $1.38. Sales grew 2.3% to $7.72 billion, below the FactSet consensus of $7.81 billion, as the company's cardiac and vascular and minimally invasive therapies segments missed expectations, the restorative therapies sales were in line and the diabetes segment sales topped expectations. The company raised its full-year EPS guidance range to $5.63 to $5.65 from $5.57 to $5.63. The stock has gained 5.5% over the past three months through Friday, while the SPDR Health Care Select Sector ETF has tacked on 7.0% and the S&P 500 has advanced 8.3%.
- GlobeNewswire
Medtronic Reports Third Quarter Financial Results
Revenue of $7.7 Billion Increased 2.3% Reported and 2.6% Organic GAAP Diluted EPS of $1.42 Increased 51%; Non-GAAP Diluted EPS of $1.44 Increased 12% Cash Flow from Operations.
- Investing.com
Medtronic Stock Falls 3%
Investing.com - Medtronic (NYSE:MDT) Stock fell by 3.01% to trade at $113.77 by 09:40 (14:40 GMT) on Tuesday on the NYSE exchange.
- Investing.com
Medtronic Earnings Beat, Revenue Misses In Q3
Investing.com - Medtronic reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
- Investor's Business Daily
Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out
Futures: Walmart, Medtronic and InMode earnings are due Tuesday. IPO stocks InMode, Progyny, Ping are near buy points. So is Taiwan Semiconductor. Buffett-boosted RH is likely to break out.
- Zacks
Has Medtronic (MDT) Outpaced Other Medical Stocks This Year?
Is (MDT) Outperforming Other Medical Stocks This Year?
- Zacks
Medtronic Buys Digital Surgery, Boosts AI-Focus Surgical Care
Medtronic (MDT) to integrate Digital Surgery's business within its Surgical Robotics arm, in turn augmenting the company's position in the field of surgical AI.
- Benzinga
The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions
Editor's note: This story has been updated to reflect the FDA's approval Friday of Agile Therapeutics' hormonal contraceptive patch Twirla. Biotech stocks were quiet in the week ending Feb. 14 amid some ...
- MarketWatch
Not one S&P 500 CEO is donating to Bernie Sanders or Elizabeth Warren
While the moderate 2020 Democrats finished behind Bernie Sanders in New Hampshire, presidential hopefuls Amy Klobuchar, Pete Buttigieg and Joe Biden are winning over S&P 500 CEOs, as the execs vote for them with their wallets.
- American City Business Journals
Medtronic buys British surgical AI company called Digital Surgery
London-based Digital Surgery has 130 employees and makes an AI technology that identifies steps in a surgery and which tools are needed for that surgery.
- MarketWatch
Medtronic recalls some insulin pumps
Shares of Medtronic PLC were up 0.36% in trading on Thursday. The Food and Drug Administration said Wednesday that Medtronic had issued a recall of its MiniMed 600 Series Insulin Pumps after reports of 2,175 injuries and one death. The regulator said it is the most serious type of recall. A missing piece can cause incorrect dosing, which can lead to hypoglycemia or hyperglycemia in the Type 1 diabetes patients who use the device. Medtronic first notified affected patients of the recall in November. Medtronic's stock has gained 29% over the past year, while the S&P 500 is up 23%.
- American City Business Journals
Medtronic recalling some MiniMed insulin pumps
Medtronic's "artificial pancreas" is the subject of a recall notice after it was discovered that a part of the device can be damaged, causing the device to malfunction. The FDA declared the recall of Medtronic's MiniMed 600 series insulin pumps a Class I recall on Wednesday, its most serious classification. Medtronic is aware of 2,175 possible injuries due to device malfunction, as well as one possible death.
- GlobeNewswire
Medtronic to Advance Solutions and Capabilities in Surgical Data and Analytics with Acquisition of Digital Surgery
DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. The acquisition of Digital Surgery will strengthen the Medtronic robotic assisted surgery platform and has applicability for the Medtronic broader portfolio. “Capabilities and solutions in the data and analytics space play a critical role in our continued focus on advancing minimally invasive surgery – from education and training, to clinical decision support, to reducing cost and unwarranted variability,” said Megan Rosengarten, vice president and general manager of the Surgical Robotics business, which is part of the Minimally Invasive Therapies Group at Medtronic.
- Zacks
Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More
Strong foothold in the emerging markets so far widely contributes to some of the industry players' Q4 results.
- Zacks
Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Medtronic (MDT) to Report Q3 Earnings: What's in Store?
In the fiscal third quarter, Medtronic (MDT) is expected to have registered strong growth for TAVR across the United States, courtesy of its higher adoption by the low-risk patient population.
- GlobeNewswire
Medtronic and the Medtronic Foundation Commit More Than $1M to Coronavirus Efforts
DUBLIN, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to coronavirus relief efforts across the globe.
- American City Business Journals
Georgia Tech alum pledges $18M, new Tech Square tower to be named for him
The Board of Regents of the University System of Georgia on Feb. 11 approved the naming of one of the towers being constructed as part of Phase III of Tech Square in honor of William W. "Bill" George and his wife Penny George.
- Investor's Business Daily
Not Finding ETFs In Buy Areas? Here's One That Beats The S&P 500
Few funds in IBD's ETF Leaders screen are in buy areas, but iShares U.S. Medical Devices is one of the exceptions, and it's been a good investment in the long run as well.
